Market Cap 128.03M
Revenue (ttm) 71.61M
Net Income (ttm) -48.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -67.85%
Debt to Equity Ratio -1.99
Volume 339,700
Avg Vol 244,630
Day's Range N/A - N/A
Shares Out 30.78M
Stochastic %K 42%
Beta 1.87
Analysts Strong Sell
Price Target $7.17

Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to...

Industry: Medical Devices
Sector: Healthcare
Phone: 661 367 9170
Fax: 661 367 9180
Address:
28159 Avenue Stanford, Suite 220, Valencia, United States
BeefStewart
BeefStewart Jun. 4 at 8:01 PM
$RCEL stronger volume today.
0 · Reply
BeefStewart
BeefStewart Jun. 4 at 2:15 PM
0 · Reply
BeefStewart
BeefStewart Jun. 4 at 2:05 PM
0 · Reply
BeefStewart
BeefStewart Jun. 3 at 3:18 PM
$RCEL https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-1c6f48121d73.html
0 · Reply
Darkryder
Darkryder Jun. 2 at 6:06 PM
$RCEL I wish their sales team would go after the cosmetics industry 💄
0 · Reply
alexpitti
alexpitti Jun. 1 at 9:08 PM
in the next 2 weeks i'm talking to ceos of $DCTH $RCEL $DMAC likely $LRMR and sophrosyne which is a private company
2 · Reply
BeefStewart
BeefStewart Jun. 1 at 5:45 PM
0 · Reply
BeefStewart
BeefStewart Jun. 1 at 3:26 PM
$RCEL I believe patience is required until at least after next ER. Looks like it's priced as if it's failing; but the real story for me continues to be in the strength of Q1, guidance being reaffirmed, and the CEO expressing that he anticipates meeting or beating guidance (possibly meaning beating the low end; but I figure with 10% sequential growth Q over Q, there is no way they don't beat the top end as well). I anticipate that revenue may come in at or above 89.5M, based on my belief that they will see at least 10% sequential growth Q over Q this year. I would also not deem it impossible for them to achieve much more than that. If Q4 were to come in around 25.6+ million, and they guided for continued growth into 2027, then it would be very likely that they achieve cash-flow breakeven by Q4 of this year or Q1 of 2027, with profitability in reach. This is worth double today, in my opinion, and I think the reason we're not seeing that is simply because of investor skepticism.
0 · Reply
josegodoy
josegodoy May. 31 at 1:06 PM
$RCEL watching this one
1 · Reply
BeefStewart
BeefStewart May. 29 at 6:19 PM
$RCEL I feel that patience is needed here. I understand how it can feel difficult to be patient for those who were invested earlier than I was, but I truly believe that there are brighter days ahead for those invested here. Just my opinion, of course.
0 · Reply
Latest News on RCEL
AVITA Medical Transcript: Status update

May 20, 2026, 7:00 PM EDT - 15 days ago

AVITA Medical Transcript: Status update


AVITA Medical to Host Investor Webinar Briefing

May 17, 2026, 6:00 PM EDT - 18 days ago

AVITA Medical to Host Investor Webinar Briefing


Avita Medical upgraded to Buy from Hold at Lake Street

2026-05-15T14:04:59.000Z - 20 days ago

Avita Medical upgraded to Buy from Hold at Lake Street


Avita Medical reports Q1 EPS (35c), consensus (38c)

2026-05-14T21:16:14.000Z - 21 days ago

Avita Medical reports Q1 EPS (35c), consensus (38c)


AVITA Medical Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 21 days ago

AVITA Medical Earnings Call Transcript: Q1 2026


AVITA Medical Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 21 days ago

AVITA Medical Earnings release: Q1 2026


AVITA Medical Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 21 days ago

AVITA Medical Quarterly report: Q1 2026


AVITA Medical Slides: Q1 2026

May 14, 2026, 4:30 PM EDT - 21 days ago

AVITA Medical Slides: Q1 2026


AVITA Medical Reports First Quarter 2026 Financial Results

May 14, 2026, 4:05 PM EDT - 21 days ago

AVITA Medical Reports First Quarter 2026 Financial Results


Avita Medical appoints Cary Vance as CEO

2026-04-30T19:27:03.000Z - 5 weeks ago

Avita Medical appoints Cary Vance as CEO


AVITA Medical Names Cary Vance as Chief Executive Officer

Apr 30, 2026, 8:50 AM EDT - 5 weeks ago

AVITA Medical Names Cary Vance as Chief Executive Officer


Avita Medical receives regulatory clearance for Recell Go

2026-04-29T21:09:12.000Z - 5 weeks ago

Avita Medical receives regulatory clearance for Recell Go


AVITA Medical to Announce First Quarter 2026 Financial Results

Apr 23, 2026, 4:10 PM EDT - 6 weeks ago

AVITA Medical to Announce First Quarter 2026 Financial Results


AVITA Medical Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 6 weeks ago

AVITA Medical Proxy statement: Proxy filing


AVITA Medical Transcript: KOL event

Apr 16, 2026, 4:30 PM EDT - 7 weeks ago

AVITA Medical Transcript: KOL event


AVITA Medical Slides: KOL event

Apr 16, 2026, 4:30 PM EDT - 7 weeks ago

AVITA Medical Slides: KOL event


AVITA Medical, Inc. Investigated by the Portnoy Law Firm

Apr 13, 2026, 9:00 AM EDT - 7 weeks ago

AVITA Medical, Inc. Investigated by the Portnoy Law Firm


Avita Medical secures 10-year BARDA agreement worth $25.5M

2026-04-08T20:21:41.000Z - 2 months ago

Avita Medical secures 10-year BARDA agreement worth $25.5M


AVITA Medical Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 2 months ago

AVITA Medical Proxy statement: Proxy filing


AVITA Medical Registration statement: Registration filing

Mar 31, 2026, 8:00 AM EDT - 2 months ago

AVITA Medical Registration statement: Registration filing


Avita Medical initiated with an Outperform at Northland

2026-03-05T14:13:45.000Z - 3 months ago

Avita Medical initiated with an Outperform at Northland


Avita Medical initiated with an Outperform at Northland

2026-03-05T12:51:41.000Z - 3 months ago

Avita Medical initiated with an Outperform at Northland


AVITA Medical Transcript: Status update

Feb 18, 2026, 5:00 PM EST - 3 months ago

AVITA Medical Transcript: Status update


AVITA Medical Slides: Status update

Feb 18, 2026, 5:00 PM EST - 3 months ago

AVITA Medical Slides: Status update


Avita Medical reports Q4 EPS (38c), consensus (55c)

2026-02-12T21:55:45.000Z - 4 months ago

Avita Medical reports Q4 EPS (38c), consensus (55c)


Avita Medical sees FY26 revenue $80M-$85M, consensus $123.5M

2026-02-12T21:55:18.000Z - 4 months ago

Avita Medical sees FY26 revenue $80M-$85M, consensus $123.5M


AVITA Medical Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

AVITA Medical Earnings Call Transcript: Q4 2025


AVITA Medical Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

AVITA Medical Annual report: Q4 2025


AVITA Medical Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

AVITA Medical Earnings release: Q4 2025


AVITA Medical Slides: Q4 2025

Feb 12, 2026, 4:30 PM EST - 4 months ago

AVITA Medical Slides: Q4 2025


Avita Medical sees Q4 revenue $17.6M vs. $18.4M last year

2026-01-13T13:36:59.000Z - 5 months ago

Avita Medical sees Q4 revenue $17.6M vs. $18.4M last year


Avita Medical sees FY26 revenue $80M-$85M vs. $71.6M in FY24

2026-01-13T13:36:35.000Z - 5 months ago

Avita Medical sees FY26 revenue $80M-$85M vs. $71.6M in FY24


Avita Medical closes five-year credit facility up to $60M

2026-01-13T13:35:24.000Z - 5 months ago

Avita Medical closes five-year credit facility up to $60M


AVITA Medical Announces Changes to its Board of Directors

Jan 5, 2026, 4:05 PM EST - 5 months ago

AVITA Medical Announces Changes to its Board of Directors


Avita Medical upgraded to Neutral from Sell at BTIG

2025-11-20T11:25:41.000Z - 7 months ago

Avita Medical upgraded to Neutral from Sell at BTIG


AVITA Medical Transcript: Status Update

Nov 12, 2025, 5:00 PM EST - 7 months ago

AVITA Medical Transcript: Status Update


Avita Medical price target lowered to $3 from $4 at Lake Street

2025-11-07T13:51:50.000Z - 7 months ago

Avita Medical price target lowered to $3 from $4 at Lake Street


Avita Medical reports Q3 EPS (46c), consensus (45c)

2025-11-06T23:20:28.000Z - 7 months ago

Avita Medical reports Q3 EPS (46c), consensus (45c)


AVITA Medical Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

AVITA Medical Earnings Call Transcript: Q3 2025


AVITA Medical Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

AVITA Medical Quarterly report: Q3 2025


AVITA Medical Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

AVITA Medical Earnings release: Q3 2025


AVITA Medical Slides: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

AVITA Medical Slides: Q3 2025


AVITA Medical to Announce Third Quarter 2025 Financial Results

Oct 29, 2025, 4:15 PM EDT - 7 months ago

AVITA Medical to Announce Third Quarter 2025 Financial Results


AVITA Medical Announces CEO Transition

Oct 16, 2025, 6:15 PM EDT - 8 months ago

AVITA Medical Announces CEO Transition


AVITA Medical Successfully Completes Australian Equity Raise

Aug 12, 2025, 8:30 AM EDT - 10 months ago

AVITA Medical Successfully Completes Australian Equity Raise


AVITA Medical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

AVITA Medical Earnings Call Transcript: Q2 2025


AVITA Medical Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

AVITA Medical Quarterly report: Q2 2025


AVITA Medical Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

AVITA Medical Earnings release: Q2 2025


AVITA Medical Slides: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

AVITA Medical Slides: Q2 2025


AVITA Medical to Announce Second Quarter 2025 Financial Results

Jul 28, 2025, 4:05 PM EDT - 11 months ago

AVITA Medical to Announce Second Quarter 2025 Financial Results


AVITA Medical Transcript: Status Update

May 13, 2025, 2:00 PM EDT - 1 year ago

AVITA Medical Transcript: Status Update


AVITA Medical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Earnings Call Transcript: Q1 2025


AVITA Medical Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Quarterly report: Q1 2025


AVITA Medical Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Earnings release: Q1 2025


AVITA Medical Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

AVITA Medical Slides: Q1 2025


AVITA Medical Reports First Quarter 2025 Financial Results

May 8, 2025, 4:03 PM EDT - 1 year ago

AVITA Medical Reports First Quarter 2025 Financial Results


AVITA Medical Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

AVITA Medical Proxy statement: Proxy Filing


AVITA Medical Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

AVITA Medical Proxy statement: Proxy Filing


AVITA Medical Transcript: Investor Update

Feb 18, 2025, 5:00 PM EST - 1 year ago

AVITA Medical Transcript: Investor Update


AVITA Medical Earnings Call Transcript: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Earnings Call Transcript: Q4 2024


AVITA Medical Annual report: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Annual report: Q4 2024


AVITA Medical Earnings release: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Earnings release: Q4 2024


AVITA Medical Slides: Q4 2024

Feb 13, 2025, 4:30 PM EST - 1 year ago

AVITA Medical Slides: Q4 2024


AVITA Medical's shares sink 19% after another forecast cut

Jan 7, 2025, 10:12 PM EST - 1 year ago

AVITA Medical's shares sink 19% after another forecast cut


BeefStewart
BeefStewart Jun. 4 at 8:01 PM
$RCEL stronger volume today.
0 · Reply
BeefStewart
BeefStewart Jun. 4 at 2:15 PM
0 · Reply
BeefStewart
BeefStewart Jun. 4 at 2:05 PM
0 · Reply
BeefStewart
BeefStewart Jun. 3 at 3:18 PM
$RCEL https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-1c6f48121d73.html
0 · Reply
Darkryder
Darkryder Jun. 2 at 6:06 PM
$RCEL I wish their sales team would go after the cosmetics industry 💄
0 · Reply
alexpitti
alexpitti Jun. 1 at 9:08 PM
in the next 2 weeks i'm talking to ceos of $DCTH $RCEL $DMAC likely $LRMR and sophrosyne which is a private company
2 · Reply
BeefStewart
BeefStewart Jun. 1 at 5:45 PM
0 · Reply
BeefStewart
BeefStewart Jun. 1 at 3:26 PM
$RCEL I believe patience is required until at least after next ER. Looks like it's priced as if it's failing; but the real story for me continues to be in the strength of Q1, guidance being reaffirmed, and the CEO expressing that he anticipates meeting or beating guidance (possibly meaning beating the low end; but I figure with 10% sequential growth Q over Q, there is no way they don't beat the top end as well). I anticipate that revenue may come in at or above 89.5M, based on my belief that they will see at least 10% sequential growth Q over Q this year. I would also not deem it impossible for them to achieve much more than that. If Q4 were to come in around 25.6+ million, and they guided for continued growth into 2027, then it would be very likely that they achieve cash-flow breakeven by Q4 of this year or Q1 of 2027, with profitability in reach. This is worth double today, in my opinion, and I think the reason we're not seeing that is simply because of investor skepticism.
0 · Reply
josegodoy
josegodoy May. 31 at 1:06 PM
$RCEL watching this one
1 · Reply
BeefStewart
BeefStewart May. 29 at 6:19 PM
$RCEL I feel that patience is needed here. I understand how it can feel difficult to be patient for those who were invested earlier than I was, but I truly believe that there are brighter days ahead for those invested here. Just my opinion, of course.
0 · Reply
JHR
JHR May. 28 at 5:08 PM
$RCEL 4.62 close today 💪🙂
1 · Reply
BeefStewart
BeefStewart May. 28 at 2:39 PM
$RCEL we know dilution is very likely; but I believe it will occur after a very strong Q2 ER and at a significantly higher share price.
0 · Reply
BeefStewart
BeefStewart May. 28 at 2:39 PM
$RCEL I believe this is a steal at these prices...
0 · Reply
JHR
JHR May. 27 at 11:00 PM
$RCEL CFO David O'Toole is a believer 💪
1 · Reply
BeefStewart
BeefStewart May. 27 at 4:46 PM
$RCEL The CFO made what I can only describe as a symbolic open-market purchase of 2k shares... I would like to see the CEO make a larger open-market purchase before Q2 earnings... Not sure if he is restricted from doing so...
0 · Reply
BeefStewart
BeefStewart May. 27 at 2:24 PM
$RCEL while their cash position is rough, I believe the real magic is in their anticipated revenue trajectory. If Q1 showed 19.3M and January was a very slow month, I believe Q2 sales will show a minimum of $21.23M in revenue, representing a minimum of 10% sequential growth. I believe it is very possible that we see $25M+ in revenues in Q4. If growth continues sequentially into 2027, which I believe it will, then they will have achieved cashflow breakeven by then. The sky is the limit here, in my opinion.
0 · Reply
JHR
JHR May. 27 at 2:20 PM
0 · Reply
BeefStewart
BeefStewart May. 26 at 8:18 PM
$RCEL relatively large buying in the last 10 minutes of trading...
0 · Reply
JHR
JHR May. 26 at 5:15 PM
0 · Reply
BeefStewart
BeefStewart May. 26 at 2:41 PM
$RCEL I view this as simply being forgotten or generally unfollowed. I believe there will be brighter days ahead, but I also believe that we have to kinda just sit tight between quarters. Investors need to see proof that there is a pathway towards breakeven and that the revenue growth trends are real. I believe this is very undervalued at these levels, but the market may disagree with me at this time...
1 · Reply
BeefStewart
BeefStewart May. 26 at 1:56 PM
0 · Reply
BeefStewart
BeefStewart May. 22 at 4:19 PM
$RCEL Just modeling 10% sequential growth quarter over quarter to see how that looks.
0 · Reply